Healthcare Realty Trust (NYSE:HR) Updates FY 2025 Earnings Guidance

Healthcare Realty Trust (NYSE:HR) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.560-1.600 for the period, compared to the consensus earnings per share estimate of 1.590. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. JPMorgan Chase & Co. downgraded shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price target on the stock. in a research report on Friday, December 20th. Jefferies Financial Group downgraded shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and decreased their price target for the stock from $19.00 to $17.00 in a research report on Thursday, January 2nd. Finally, Wedbush downgraded shares of Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $18.00 to $16.00 in a research report on Thursday, January 2nd. Two investment analysts have rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. Based on data from MarketBeat, Healthcare Realty Trust currently has a consensus rating of “Hold” and a consensus price target of $17.00.

Healthcare Realty Trust Stock Performance

Shares of HR stock opened at $16.98 on Wednesday. The company’s fifty day moving average price is $16.69 and its 200-day moving average price is $17.42. Healthcare Realty Trust has a one year low of $12.77 and a one year high of $18.90.

Healthcare Realty Trust (NYSE:HR) last posted its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.01. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. Equities research analysts predict that Healthcare Realty Trust will post 1.55 EPS for the current fiscal year.

Insider Activity at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian acquired 7,750 shares of the company’s stock in a transaction on Friday, November 22nd. The stock was acquired at an average cost of $17.39 per share, with a total value of $134,772.50. Following the purchase, the director now directly owns 50,002 shares of the company’s stock, valued at approximately $869,534.78. This represents a 18.34 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Robert E. Hull sold 10,000 shares of Healthcare Realty Trust stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $17.48, for a total transaction of $174,800.00. Following the completion of the transaction, the chief operating officer now directly owns 171,400 shares of the company’s stock, valued at $2,996,072. The trade was a 5.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders purchased 18,750 shares of company stock valued at $323,723. Corporate insiders own 0.56% of the company’s stock.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.